Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lobbied select members of the House and Senate on H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
C R BARD INC via C. R. BARD, INC.
2009 · second_quarter · 2T
H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
H.R. 422 (to amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit).
Source: Senate LDA
To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit.
Client: C R BARD INC · Firm: C. R. BARD, INC.
H.R. 422 (to amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit).
H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Lobbied select members of the House and Senate on H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
H.R. 1908 and S. 1145
H.R. 1908 and S. 1145, "Patent Reform Act of 2007"; specifically provisions related to apportionment and second window language.
S. 2209 and H.R. 2138
S. 2209, "Research Credit Improvement Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit. H.R. 2138, "Investment in America Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the bill.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042, "Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007," to exclude ultrasound guided vascular access procedures from the bill.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Seek physician payment fix for certain products covered under Medicare's Physican Fee Schedule Payment rule for 2008.
Medicare Improvements for Patients and Providers Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Medicare Improvements for Patients and Providers Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Seek physician payment fix for certain products covered under Medicare's Physican Fee Schedule Payment rule for 2008.
Renewable Energy and Job Creation Tax Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Renewable Energy and Job Creation Tax Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Renewable Energy and Job Creation Tax Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Seek physician payment fix for certain products covered under Medicare's Physican Fee Schedule Payment rule for 2008.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042, "Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007," to exclude ultrasound guided vascular access procedures from the bill.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the bill.
H.R. 1908 and S. 1145, "Patent Reform Act of 2007"; specifically provisions related to apportionment and second window language.
H.R. 1908 and S. 1145
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
S. 2221 and S. 2029
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
S. 2209 and H.R. 2138
S. 2209, "Research Credit Improvement Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit. H.R. 2138, "Investment in America Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit.
Transparency in Medical Device Pricing Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Transparency in Medical Device Pricing Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Transparency in Medical Device Pricing Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Transparency in Medical Device Pricing Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
S. 2221 and S. 2029
Alternative Minimum Tax and Extenders Tax Relief Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
S. 2886, "Alternative Minimum Tax and Extenders Tax Relief Act of 2008" and H.R. 6049, "Renewable Energy and Job Creation Act of 2008"; specifically extending and strengthening the R&D tax credit until December 31, 2009.
Medicare Improvements for Patients and Providers Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Medicare Improvements for Patients and Providers Act of 2008
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Seek physician payment fix for certain products covered under Medicare's Physican Fee Schedule Payment rule for 2008.
Lobbying Senate Finance Committee staff and House staff on provisions in the Baucus-Conrad comparative effective bill, S. 3408, "The Comparative Effectiveness Research Act of 2008", and Section 904 of H.R. 3162, "Children's Health and Medicare Protection Act of 2007." Prepared materials for potential use in a public awareness campaign on prostate cancer in Congressional District of Rep. Jim Clyburn. Discussion of same with Clyburn staff. Lobbying strategy prepared for key provisions in "FDA Globalization Act" and Ensuring the Safety and Quality of Medical Products Act." Lobbying CMS Coverage Advisory Group regarding Medicare coverage of bariatric surgery device.
Lobbying Senate Finance Committee staff and House staff on provisions in the Baucus-Conrad comparative effective bill, S. 3408, "The Comparative Effectiveness Research Act of 2008", and Section 904 of H.R. 3162, "Children's Health and Medicare Protection Act of 2007." Prepared materials for potential use in a public awareness campaign on prostate cancer in Congressional District of Rep. Jim Clyburn. Discussion of same with Clyburn staff. Lobbying strategy prepared for key provisions in "FDA Globalization Act" and Ensuring the Safety and Quality of Medical Products Act." Lobbying CMS Coverage Advisory Group regarding Medicare coverage of bariatric surgery device.
American Samoa Possession Tax Credit Act of 2003
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
American Samoa Possession Tax Credit Act of 2003
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
American Samoa Possession Tax Credit Act of 2003
Client: C R BARD INC · Firm: C. R. BARD, INC.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
H.R. 2419 (provisions related to use of live animals in the testing and training of new medical devices); Senate Farm bill.
H.R. 1908 and S. 1145
S. 2209 and H.R. 2138
H.R. 1908 and S. 1145
S. 2221 and S. 2029
S. 2209 and H.R. 2138
Transparency in Medical Device Pricing Act of 2007
Client: C R BARD INC · Firm: C. R. BARD, INC.
S. 2221 and S. 2029
H.R. 2419 (provisions related to use of live animals in the testing and training of new medical devices); Senate Farm Bill
Health care policy issues; health care regulatory issues; and health care reform legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2009 · first_quarter · Q1
Lobbied select members of the House and Senate on H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Lobbying Senate Finance Committee staff and House staff on comparative effectiveness provisions of HR1 American Recovery and Reinvestment Act of 2009. Continued discussions with Rep. Jim Clyburn's staff regarding potential public awareness campaign on prostate cancer in South Carolina. Discussed potential site visit by Sen. Max Baucus to Bard facility to discuss general health care reform issues. Lobbying strategy and materials prepared regarding HICPAC guidelines for CAUTIs (expected release April 2009).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2008 · fourth_quarter · 4A
Lobbying Senate Finance Committee staff and House staff on provisions in the Baucus-Conrad comparative effective bill, S. 3408, "The Comparative Effectiveness Research Act of 2008", and Section 904 of H.R. 3162, "Children's Health and Medicare Protection Act of 2007." Prepared materials for potential use in a public awareness campaign on prostate cancer in Congressional District of Rep. Jim Clyburn. Discussion of same with Clyburn staff. Lobbying strategy prepared for key provisions in "FDA Globalization Act" and Ensuring the Safety and Quality of Medical Products Act." Lobbying CMS Coverage Advisory Group regarding Medicare coverage of bariatric surgery device.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2008 · fourth_quarter · Q4
Lobbying Senate Finance Committee staff and House staff on provisions in the Baucus-Conrad comparative effective bill, S. 3408, "The Comparative Effectiveness Research Act of 2008", and Section 904 of H.R. 3162, "Children's Health and Medicare Protection Act of 2007." Prepared materials for potential use in a public awareness campaign on prostate cancer in Congressional District of Rep. Jim Clyburn. Discussion of same with Clyburn staff. Lobbying strategy prepared for key provisions in "FDA Globalization Act" and Ensuring the Safety and Quality of Medical Products Act." Lobbying CMS Coverage Advisory Group regarding Medicare coverage of bariatric surgery device.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2008 · third_quarter · Q3
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2008 · first_quarter · 1A
H.R. 1908 and S. 1145, "Patent Reform Act of 2007"; specifically provisions related to apportionment and second window language.
H.R. 2419, "Farm, Nutrition and Bioenergy Act of 2007"; specifically those provisions related to use of live animals in the testing and training of new medical devices contained in the Senate Farm Bill.
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042, "Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007," to exclude ultrasound guided vascular access procedures from the bill.
C R BARD INC via C. R. BARD, INC.
2008 · second_quarter · Q2
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Seek physician payment fix for certain products covered under Medicare's Physican Fee Schedule Payment rule for 2008.
C R BARD INC via C. R. BARD, INC.
2008 · first_quarter · Q1
H.R. 2419 (provisions related to use of live animals in the testing and training of new medical devices); Senate Farm bill.
S. 2209 and H.R. 2138
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the bill.
C R BARD INC via C. R. BARD, INC.
2007 · year_end · YY
H.R. 2419 (provisions related to use of live animals in the testing and training of new medical devices); Senate Farm Bill
H.R. 1908 and S. 1145
Japan trade relations, House Energy and Commerce Hearing
C R BARD INC via C. R. BARD, INC.
2007 · mid_year · MM
Lobbying Members of Congress to support medical device industry priorities in Medical Device User Fee Modernization Act reauthorization.
Lobbying Members of Congress on trade issues, particularly with respect to Japan.
Lobbying members of House and Senate to delay implementation of changes to Medicare brachytherapy reimbursement payment methodology in CMS's final OPPS rule. Seek inclusion of specific infections listed in CMS's Inpatient Rule due out in August 2007.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2006 · year_end · YY
Lobbying members of Congress to seek a delay in the implementation of CMS's final rule on the Medicare Inpatient Prospective Payment System. Lobbying members of House and Senate to delay implementation of changes to Medicare brachytherapy reimbursement payment methodology in CMS's final OPPS rule.
Lobbying for full Appropriations of the President's FY '07 budget for the Food and Drug Administration.
Such actions would be anti-competitive, costly to American med tech companies, and a technical barrier to trade with Australia Lobbying Dept. of Commerce staff on Australian government's plan to mandate the exclusive use of the EAN bar coding system for medical devices, and the plan to develop a National Product Catalogue.
C R BARD INC via C. R. BARD, INC.
2006 · mid_year · MA
Lobbying House Government Reform Committee staff on the patient health safety risks involved in the reuse of single use medical devices.
Lobbying members of Congress to seek a delay in the implementation of CMS's final rule on the Medicare Inpatient Prospective Payment System.
Lobbying for full Appropriations of the President's FY '07 budget for the Food and Drug Administration.
C R BARD INC via C. R. BARD, INC.
2006 · mid_year · MM
Lobbying House Government Reform Committee staff on the patient health safety risks involved in the reuse of single use medical devices.
Lobbying members of Congress to seek a delay in the implementation of CMS's final rule on the Medicare Inpatient Prospective Payment System.
Lobbying Dept. of Commerce staff on Australian government's plan to mandate the exclusive use of the EAN bar coding system for medical devices, and the plan to develop a National Product Catalogue. Such actions would be anti-competitive, costly to American med tech companies, and a technical barrier to trade with Australia. Lobbying regarding Japanese trade issues generally.
C R BARD INC via C. R. BARD, INC.
2006 · mid_year · MA
Lobbying House Government Reform Committee staff on the patient health safety risks involved in the reuse of single use medical devices.
Lobbying members of Congress to seek a delay in the implementation of CMS's final rule on the Medicare Inpatient Prospective Payment System.
Lobbying Dept. of Commerce staff on Australian government's plan to mandate the exclusive use of the EAN bar coding system for medical devices, and the plan to develop a National Product Catalogue. Such actions would be anti-competitive, costly to American med tech companies, and a technical barrier to trade with Australia. Lobbying regarding Japanese trade issues generally.
C R BARD INC via C. R. BARD, INC.
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2005 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
C R BARD INC via C. R. BARD, INC.
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2003 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
C R BARD INC via C. R. BARD, INC.
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2002 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
C R BARD INC via C. R. BARD, INC.
2002 · year_end · RR
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
S. 2209, "Research Credit Improvement Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit. H.R. 2138, "Investment in America Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 2886, "Alternative Minimum Tax and Extenders Tax Relief Act of 2008" and H.R. 6049, "Renewable Energy and Job Creation Act of 2008"; specifically extending and strengthening the R&D tax credit until December 31, 2009.
H.R. 2419, "Farm, Nutrition and Bioenergy Act of 2007"; specifically those provisions related to use of live animals in the testing and training of new medical devices contained in the Senate Farm Bill.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 1908 and S. 1145
S. 2221 and S. 2029
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 2221 and S. 2029
Lobbying members of Congress (staff) to support medical device industry priorities in Medical Device User Fee Modernization Act reauthorization.
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule.
S. 2209 and H.R. 2138
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Lobbying House Government Reform Committee staff on the patient health safety risks involved in the reuse of single use medical devices.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Lobbying Dept. of Commerce staff on Australian government's plan to mandate the exclusive use of the EAN bar coding system for medical devices, and the plan to develop a National Product Catalogue. Such actions would be anti-competitive, costly to American med tech companies, and a technical barrier to trade with Australia. Lobbying regarding Japanese trade issues generally.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Lobbying for full Appropriations of the President's FY '07 budget for the Food and Drug Administration.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Lobbying for full Appropriations of the President's FY '07 budget for the Food and Drug Administration.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE